Yan Li

发表

Carbapenems vs alternative antibiotics for the treatment of complicated urinary tract infection

Xinmei Tan, Q. Pan, C. Mo, 2020, Medicine.

Atezolizumab plus bevacizumab versus nivolumab as first‐line treatment for advanced or unresectable hepatocellular carcinoma: A cost‐effectiveness analysis

Xueyan Liang, Yan Li, Huijuan Li, 2022, Cancer.

Efficacy and safety of optional parenteral antimicrobial therapy for complicated skin and soft tissue infections: A systematic review and Bayesian network meta-analysis

Xueyan Liang, Yan Li, S. Guo, 2022, Medicine.

Safety and efficacy of combined use of propofol and etomidate for sedation during gastroscopy

Xinmei Tan, Xueyan Liang, Yan Li, 2019, Medicine.

Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis

Xueyan Liang, Yan Li, S. Guo, 2022, Frontiers in Oncology.

Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma

Huajun Zhang, Xueyan Liang, Yan Li, 2022, Medicine.

Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Xueyan Liang, Yan Li, Huijuan Li, 2022, Frontiers in pharmacology.

Safety and efficacy of combined use of propofol and etomidate for sedation during gastroscopy

Xinmei Tan, Xueyan Liang, Yan Li, 2019, Medicine.

a systematic review and meta-analysis A randomized controlled trial

Xianshu Li, Xueyan Liang, Yan Li, 2019 .

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis

Yan Li, S. Guo, Xiaoyu Chen, 2021, Pharmaceutical biology.

Comparative efficacy and safety of antipseudomonal b-lactams for pediatric febrile neutropenia A systematic review and Bayesian network meta-analysis

Xinmei Tan, Xueyan Liang, Yan Li, 2021 .

Clinical efficacy and safety of Huachansu injection combination with platinum-based chemotherapy for advanced non-small cell lung cancer

Xinmei Tan, Xueyan Liang, Yan Li, 2021, Medicine.

Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia

Xianshu Li, Xueyan Liang, Yan Li, 2020, Medicine.

Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis.

Xueyan Liang, Yan Li, Huijuan Li, 2023, International immunopharmacology.

Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections

Xianshu Li, Xueyan Liang, Yan Li, 2019, Medicine.

A Bayesian network meta-analysis of randomized clinical trials

Xianshu Li, Xueyan Liang, Yan Li, 2019 .

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer

Xueyan Liang, Yan Li, Huijuan Li, 2023, Frontiers in Oncology.

Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis

Xueyan Liang, Yan Li, Huijuan Li, 2023, Frontiers in Endocrinology.

Tislelizumab plus chemotherapy is more cost-effective than chemotherapy alone as first-line therapy for advanced non-squamous non-small cell lung cancer

Xueyan Liang, Yan Li, Huijuan Li, 2023, Frontiers in Public Health.

Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia

Xinmei Tan, Xueyan Liang, Yan Li, 2021, Medicine.

Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis

Xianshu Li, Xueyan Liang, Yan Li, 2020, Pharmaceutical biology.

New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis

Chunxiang Luo, Yu Liu, Xueyan Liang, 2022, Computational and mathematical methods in medicine.

Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

Xueyan Liang, Yan Li, Lingyuan Chen, 2023, Frontiers in Oncology.

Sugemalimab plus chemotherapy vs. chemotherapy for metastatic non-small-cell lung cancer: A cost-effectiveness analysis

Xueyan Liang, Yan Li, Huijuan Li, 2023, Frontiers in Public Health.

Cost-effectiveness of camrelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer.

Xueyan Liang, Yan Li, Huijuan Li, 2023, Immunotherapy.

Carbapenems vs alternative antibiotics for the treatment of complicated urinary tract infection

Xinghuan Wang, Ping Chen, Xinhua Zhang, 2020, Medicine.

Carbapenems vs β-Lactam Monotherapy or Combination Therapy for the Treatment of Complicated Intra-abdominal Infections: Systematic Review and Meta-analysis of Randomized Controlled Trials

Xianshu Li, Xueyan Liang, Yan Li, 2019, Open forum infectious diseases.

Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis

Xueyan Liang, Yan Li, Huijuan Li, 2023, Chinese medical journal.

Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer

Xueyan Liang, Yan Li, Huijuan Li, 2023, Frontiers in public health.

Optimal Chinese herbal injections plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A systematic review and Bayesian network meta-analysis

Xueyan Liang, Yan Li, S. Guo, 2021 .